Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1984-10-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0093-7711
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
197-204
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:6432686-Animals,
pubmed-meshheading:6432686-Genes, Dominant,
pubmed-meshheading:6432686-Genes, MHC Class II,
pubmed-meshheading:6432686-HLA Antigens,
pubmed-meshheading:6432686-HLA-B27 Antigen,
pubmed-meshheading:6432686-Humans,
pubmed-meshheading:6432686-Immunity, Innate,
pubmed-meshheading:6432686-Mice,
pubmed-meshheading:6432686-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:6432686-Virus Diseases
|
pubmed:year |
1984
|
pubmed:articleTitle |
HLA-B27, a dominant restricting element in antiviral responses?
|
pubmed:publicationType |
Journal Article
|